Astellas and Pioneer Group Award Future Innovator Prize to ImmTune TherapiesGemma Cann2023-09-04T12:36:25+01:00March 17th, 2022|Accelerator, News|
From Kitchen Ingredient to Saving Lives – Phenotypeca Pioneers Improved Use of Baker’s YeastGemma Cann2022-06-30T11:40:43+01:00March 10th, 2022|BioCity Nottingham, News|
Recruiters Plan a Lasting Solution to Teesside’s Skills ShortageGemma Cann2022-06-30T11:41:01+01:00February 28th, 2022|News, Wilton Centre|
AMD Acquisition of Xilinx CompletesGemma Cann2023-09-04T12:38:06+01:00February 21st, 2022|Edinburgh Technopole, News|
Cellomatics Biosciences Goes for Growth with Senior Business Development HireGemma Cann2022-06-30T11:41:44+01:00February 21st, 2022|News|
Phenotypeca Wins a Third Grant from Innovate UKGemma Cann2022-06-30T11:42:06+01:00February 17th, 2022|News|
Winners Announced for Medilink Midlands Business Awards 2022Gemma Cann2022-06-30T11:42:15+01:00February 15th, 2022|News|
Nottingham CRO Bolsters Team with Appointment of Senior Molecular BiologistGemma Cann2022-06-30T11:42:47+01:00February 14th, 2022|News|
Phenotypeca Announces Commencement of Lab 4.0 ProjectGemma Cann2022-06-30T11:43:13+01:00February 4th, 2022|BioCity Nottingham, News|
Levelling Up White Paper and Life SciencesGemma Cann2022-06-30T11:43:21+01:00February 4th, 2022|Article, Headline Article|
